BF5C200
Other Imaging Hepatobiliary System, All to Intraoperative with Indocyanine Green Dye, Fluorescing Agent Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | B Imaging |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | 5 Other Imaging |
| Body Part | C Hepatobiliary System, All |
| Approach | 2 Fluorescing Agent |
| Device | 0 Indocyanine Green Dye |
| Qualifier | 0 Intraoperative |
Operation Definition
Other specified modality for visualizing a body part
Procedure Overview
Other Imaging of the hepatobiliary system and pancreas is a catch-all family for modalities that don't fit the four conventional imaging types of fluoroscopy, CT, MRI, or ultrasound. In practice, the technique most often falling here is nuclear medicine scintigraphy, such as a HIDA scan, which uses a small dose of a radioactive tracer injected into the bloodstream that the liver picks up and excretes into bile, allowing a gamma camera to track its movement over time.
A HIDA scan is ordered when acute cholecystitis is suspected but ultrasound findings are equivocal, since the tracer will fail to fill the gallbladder if the cystic duct is obstructed by inflammation or a stone. It's also used to detect bile leaks after gallbladder surgery or liver transplant, to assess gallbladder emptying function in patients with chronic biliary-type pain, and occasionally to evaluate biliary atresia in infants.
Anatomy & Axis Detail
Hepatobiliary System, All
When the liver, gallbladder, bile ducts, and pancreas are imaged together as a single functional unit under "Other Imaging," the study is typically a nuclear medicine hepatobiliary scan, such as a HIDA scan, that tracks a radiotracer as it is taken up by hepatocytes, excreted into bile, and passed through the biliary tree into the duodenum. This sequence evaluates gallbladder filling and emptying, patency of the cystic and common bile ducts, and can distinguish acute cholecystitis from chronic biliary dyskinesia or confirm a bile leak after surgery. Because the pancreas shares embryologic and ductal relationships with the biliary system, it is coded as part of this combined body part rather than imaged separately. Documentation should specify the radiotracer used and whether a pharmacologic agent, such as cholecystokinin, was administered to assess gallbladder ejection fraction.
Contrast: Fluorescing Agent
Fluorescing Agent identifies imaging performed using a fluorescent dye, such as indocyanine green, that emits light under specific wavelengths to highlight vasculature, lymphatic channels, or tissue perfusion in real time. It represents a distinct contrast mechanism from iodinated osmolar agents, relying on optical fluorescence rather than radiographic density, and is used in newer intraoperative or specialized imaging applications rather than conventional radiography.
Qualifier: Indocyanine Green Dye
Indocyanine Green Dye specifies use of this fluorescent dye, administered intravenously, to enhance visualization of blood flow, lymphatics, or tissue perfusion during imaging. It is widely used in vascular and lymphatic studies as well as intraoperative angiography. It is distinguished from Bacterial Autofluorescence, which relies on tissue's own fluorescent emission rather than an injected dye.
Qualifier: Intraoperative
This qualifier indicates that an imaging study is performed intraoperatively, meaning the images are obtained during an ongoing surgical procedure rather than as a separate diagnostic encounter. It distinguishes real-time surgical imaging from routine preoperative or postoperative studies, which carry the None qualifier instead.
Coding & Documentation
Because this is a residual category, the coder's first task is ruling out that the study wasn't actually one of the four standard modalities before assigning a code here - the report needs to clearly describe the technique used, such as radiotracer injection and gamma camera imaging for a HIDA scan, to justify placement in this family. Documentation should specify whether a pharmacologic agent like cholecystokinin was given to assess gallbladder ejection fraction, since that's a clinically meaningful part of the study even though it doesn't usually change the code itself.
A common error is defaulting studies here simply because the coder doesn't recognize the modality name in the report, when closer reading would reveal it was actually a delayed-phase CT or MRI sequence that belongs in one of the standard families instead.
Commonly Confused With
The main point of confusion is with fluoroscopic cholangiography, since both a HIDA scan and an ERCP can be loosely described as imaging the biliary tree, but a HIDA scan tracks a radioactive tracer's physiologic excretion over time rather than displaying a live x-ray image of injected contrast. It's also distinguished from ultrasound in gallbladder-emptying evaluations, since ultrasound assesses gallbladder structure and stones directly, while a HIDA scan with cholecystokinin assesses functional emptying, a distinction that matters because the two are often ordered together but are never the same code.